Cantorias, Melchor V <br/><br/>
Development of high-specific-activity (68)Ga-labeled DOTA-rhenium-cyclized alpha-MSH peptide analog to target MC1 receptors overexpressed by melanoma tumors.  [electronic resource] 

 -  Nuclear medicine and biology  Jul 2009 
 - 505-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1872-9614 
<br/><br/><label>Standard No.: </label>10.1016/j.nucmedbio.2009.01.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetic Acid--chemistry<br/>Animals<br/>Cell Line, Tumor<br/>Chromatography, High Pressure Liquid<br/>Cyclization<br/>Female<br/>Gallium Radioisotopes--chemistry<br/>Gene Expression Regulation, Neoplastic<br/>Heterocyclic Compounds, 1-Ring--chemistry<br/>Melanocyte-Stimulating Hormones--chemistry<br/>Melanoma--diagnostic imaging<br/>Mice<br/>Mice, Inbred C57BL<br/>Microwaves<br/>Positron-Emission Tomography<br/>Receptor, Melanocortin, Type 1--metabolism<br/>Rhenium--chemistry<br/>Staining and Labeling<br/>Substrate Specificity<br/>Tissue Distribution